Alara Imaging is a San Francisco healthcare technology company building a private compute platform for radiology. Its flagship product, the Alara Medical Imaging Gateway, is edge-orchestration software that sits inside a hospital and moves imaging data securely and bidirectionally between facilities and the cloud. Founded out of UCSF research, Alara serves as a CMS measure steward, giving health systems a HITRUST-certified, HIPAA- and SOC 2-compliant way to calculate and report new radiology quality measures - including a CMS-endorsed measure to standardize CT radiation doses and reduce avoidable cancer risk.
Nate Mazonson is the co-founder and CEO of Alara Imaging (Alara Gateway), a San Francisco health-tech startup building a secure gateway-as-a-service that moves radiology data between hospitals and the cloud in real time. A Dartmouth-trained environmental engineer turned Stanford MBA, he spent five years in venture capital at Cambridge Associates and Kleiner Perkins before co-founding the vertical-farming company Plenty in 2015 and then Alara in 2019. His through-line: take antiquated, high-stakes infrastructure - first food, now medical imaging - and rebuild it as modern, machine-learning-ready software.
Eden is a Latin American health-tech company building the leading cloud PACS/RIS platform for radiology - storage, viewing, AI-assisted reading, and digital delivery of medical imaging used by hospitals and clinics across 17 countries. Founded by Julián Ríos Cantú, who first became known as the teenager behind the EVA breast-cancer-detecting bra, Eden processes millions of medical images a day and has raised roughly $44M total, including a $10M round led by Sierra Ventures and a Series A in October 2025.
Julián Ríos Cantú is the co-founder and CEO of Eden, the leading cloud-native radiology operating system in Latin America. Motivated by his mother's battle with breast cancer, he began building health technology at age 16, went on to become the youngest-ever winner of the Global Student Entrepreneur Awards at 18, earned a Thiel Fellowship, and went through Y Combinator in 2018. Today, Eden processes over 13 million diagnostic studies annually across 18 countries for more than 2,200 medical institutions, backed by Sierra Ventures, Khosla Ventures, Kaszek, and notable angel investors including Leonardo DiCaprio, Ashton Kutcher, and Tony Robbins.